SCHEMBL20595685

SCHEMBL20595685

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1nc(-n2c3ccccc3c3ccccc32)c(-n2c3ccc(C)cc3c3cc(C)ccc32)c(-c2cccnc2)c1-n1c2ccc(C)cc2c2cc(C)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 2/20 0.41
MAP2K4 P45985 1/20 0.41
CYP2A6 P11509 2/20 0.40
PDE5A O76074 2/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
ALDH1A1 P00352 2/20 0.38
NPC1 O15118 2/20 0.38
TP53 P04637 2/20 0.38
RAB9A P51151 2/20 0.38
CYP3A4 P08684 2/20 0.38
KDM4E B2RXH2 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
HPGD P15428 1/20 0.38
CYP2C19 P33261 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CYP11B1 P15538 1/20 0.37
MAPT P10636 3/20 0.36
TDP1 Q9NUW8 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30339764 1.00 CYP11B2 (0.41) CYP11B2MAP2K4CYP2A6PDE5ASMN1; SMN2
SCHEMBL30339697 1.00 CYP11B2 (0.41) CYP11B2MAP2K4CYP2A6PDE5ASMN1; SMN2
SCHEMBL23223249 1.00 CYP11B2 (0.41) CYP11B2MAP2K4CYP2A6PDE5ASMN1; SMN2
SCHEMBL21888662 0.95 MAP2K4 (0.45) CYP11B2MAP2K4CYP2A6PDE5ASMN1; SMN2
SCHEMBL30339097 0.95 MAP2K4 (0.45) CYP11B2MAP2K4CYP2A6PDE5ASMN1; SMN2
SCHEMBL21889553 0.95 CYP11B2 (0.38) CYP11B2MAP2K4CYP2A6PDE5ASMN1; SMN2
SCHEMBL30709191 0.91 CYP11B1 (0.40) CYP11B2MAP2K4CYP2A6PDE5ASMN1; SMN2
SCHEMBL21888633 0.91 MAP2K4 (0.40) CYP11B2MAP2K4CYP2A6PDE5ASMN1; SMN2
SCHEMBL30338866 0.91 MAP2K4 (0.40) CYP11B2MAP2K4CYP2A6PDE5ASMN1; SMN2
SCHEMBL30339223 0.91 MAP2K4 (0.40) CYP11B2MAP2K4CYP2A6PDE5ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11555034-B2 Composition of matter for use in organic light-emitting diodes KYULUX, INC. (JP) 2023-01-17 US disclosed
EP-3642303-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES Kyulux, Inc. (JP) 2020-04-29 EP disclosed
WO-2018237393-A1 COMPOSITION OF MATTER FOR USE IN ORGANIC LIGHT-EMITTING DIODES KYULUX , INC. (JP) 2018-12-27 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11555034-B2 Composition of matter for use in organic light-emitting diodes CRY2, NDUFV3, SLCO1B3 CYP11B2 1254/4885MAP2K4 4885/4885CYP2A6 1392/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.